Poor responses in breast cancer patients may be due to several mechanisms, including relatively low PD-L1 expression, low immune cell infiltrates or low neoantigen load and insufficient corresponding cancer antigen-reactive immune responses [11,12,13,14]. The gene discussed is CD274; the disease is breast carcinoma.